Project UPLIFT for Psychogenic Non-Epileptic Seizures

Not Applicable

Completed

• Conditions: Depression; Non-Epileptic Seizure; Psychogenic Seizure; Psychogenic Non-Epileptic Seizure
• Interventions: Behavioral: Project UPLIFT

• Registration Number: NCT03329703
• Lead Sponsor: Dartmouth-Hitchcock Medical Center

Brief Summary

Developed by researchers from the Centers for Disease Control and Prevention (CDC), Project UPLIFT (Using Practice and Learning to Increase Favorable Thoughts) is a group telephone program designed to improve depression for people with epilepsy. Project UPLIFT uses evidence-based approaches of cognitive-behavioral therapy (CBT) and mindfulness-based cognitive therapy to help people manage and prevent symptoms of depression.

For people with psychogenic non-epileptic seizures, there are few treatment options for depression that address the relationship between mood and seizures. There is evidence that mindfulness-based therapy and cognitive therapy are both effective for people with non-epileptic seizures, both in treating depression and reducing seizure frequency. In this study, Project UPLIFT will be offered to patients with psychogenic non-epileptic seizures.

Project UPLIFT is facilitated by a trained clinician to groups of 4-8 patients over the telephone. The group will meet at a regular time, once a week, for 8 consecutive weeks. Participants will be assigned to one of two groups: an immediate-treatment or a waitlist control group which will begin Project UPLIFT 3 months after enrolling in the study.

Detailed Description

Upon enrollment in the study, participants will be randomly assigned to one of two groups: an immediate-treatment group, or a 3-month waitlist control group. Both groups will be given surveys to complete online, and a seizure calendar to keep track of auras, seizures, and events. The immediate-treatment group will be scheduled to start Project UPLIFT with their trained facilitator. Each of the eight weekly sessions will take place at the same day of the week and at the same time, and will last approximately one hour. Participants will have the option of using a fake-name during the telephone calls to conceal their identity during the group telephone calls.

After the 8 weekly sessions, both groups will be given a second set of online surveys to complete individually. At this time, the waitlist control group will be scheduled to start Project UPLIFT with the trained facilitator. After the waitlist group completes the final session of Project UPLIFT, both groups will complete a third and final set of online surveys, thus concluding all study procedures.

Study Timeline

• Study First Submitted: 2017-10-20
• Study First Submitted QC: 2017-10-30
• Study First Posted: 2017-11-06
• Study Start: 2018-07-23
• Primary Completion: 2020-06-30
• Study Completion: 2020-12-31
• Status Verified: 2021-09
• Last Update Submitted: 2021-09-24
• Last Update Posted: 2021-09-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 8

Inclusion Criteria

• History of psychogenic non-epileptic seizures, confirmed by study investigator.
• Literate
• Reliable telephone access

Exclusion Criteria

• Dual diagnosis of PNES with epilepsy.
• Presence of serious mental illness that will impair ability to participate.
• Presence of active suicidal ideation at baseline with intention to act.
• Severe mental disability or estimated intelligent quotient (IQ) less than 70.
• No reliable telephone access.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Immediate-Treatment	Project UPLIFT	This group will receive Project UPLIFT immediately after completing surveys.
Waitlist Control	Project UPLIFT	This group will receive Project UPLIFT after waiting approximately 3 months to begin the intervention.

Primary Outcome Measures

Name	Time	Method
80% of participants who begin Session 1 of UPLIFT will complete 80% of the sessions.	6 months	To test the feasibility of giving Project UPLIFT to patients with PNES

Secondary Outcome Measures

Name	Time	Method
Change in seizure frequency as assessed by self-report seizure questionnaire.	6 months	Change from baseline in seizure frequency on the self-report seizure questionnaire. The self-report seizure questionnaire asks participants to report the number of seizures they have had in the previous week, month, and year. There is no upper limit of the scale, and is not a standardized survey.
Change in depression (Patient Health Questionnaire-9) before and after intervention.	6 months	Change from baseline in depression scores, as reported in the Patient Health Questionnaire-9. The PHQ-9 provides a total depression score ranging from 0-27, with higher score indicating more severe depression symptoms.
Change in anxiety (Generalized Anxiety Disorder-7) before and after the intervention.	6 months	Change from baseline in anxiety scores, as reported on the Generalized Anxiety Disorder -7 survey. The GAD-7 provides a total score ranging from 0-21, with a higher score indicating more severe anxiety symptoms.
Change in symptoms of Post-Traumatic Stress Disorder (PTSD Checklist-Civilian Version, PCL-C) before and after the intervention.	6 months	Change from baseline in Post-Traumatic Stress Disorder scores as measured by the Post-Traumatic Stress Disorder Checklist - Civilian Version. The PCL-C provides a total score of PTSD severity that ranges from 17-85, with higher score indicating higher symptom severity.

Trial Locations

Locations (1)

Dartmouth-Hitchcock Medical Center; 🇺🇸 Lebanon, New Hampshire, United States